No reason to consider it, POSCO wants to enter the Lithium space and needs Spodemene , but it needs to be realised that this deal is unlikely to have any direct cash component to it, more a means to help us pay for our share and will be more than 18-24 months away producing any income, so of no lasting short term impact for PLS.
IMO what is much more important for PLS in the near term is the Partnership deal , that has the potential to have a near term impact on our cash and debt position , which is important at this stage as if it goes ahead our income will be reduced initially. It also has the potential to have any cost associated with developing stage 2 and 3 eliminated ..
Cheers Whisky
Day to day discussions on S/P, page-13091
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.01 |
Change
0.050(1.69%) |
Mkt cap ! $9.059B | |||
| Open | High | Low | Value | Volume |
| $3.03 | $3.04 | $2.96 | $47.61M | 15.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 168080 | $3.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.01 | 137639 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| PLS (ASX) Chart |